Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
McKinsey
McKesson
Accenture
US Army
Julphar
Federal Trade Commission
Farmers Insurance
Healthtrust

Generated: February 23, 2018

DrugPatentWatch Database Preview

Eflornithine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for eflornithine hydrochloride and what is the scope of eflornithine hydrochloride freedom to operate?

Eflornithine hydrochloride
is the generic ingredient in two branded drugs marketed by Skinmedica and Sanofi Aventis Us, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for eflornithine hydrochloride. Two suppliers are listed for this compound.
Pharmacology for eflornithine hydrochloride
Medical Subject Heading (MeSH) Categories for eflornithine hydrochloride

US Patents and Regulatory Information for eflornithine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Skinmedica VANIQA eflornithine hydrochloride CREAM;TOPICAL 021145-001 Jul 27, 2000 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us ORNIDYL eflornithine hydrochloride INJECTABLE;INJECTION 019879-002 Nov 28, 1990 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for eflornithine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Skinmedica VANIQA eflornithine hydrochloride CREAM;TOPICAL 021145-001 Jul 27, 2000 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us ORNIDYL eflornithine hydrochloride INJECTABLE;INJECTION 019879-002 Nov 28, 1990 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us ORNIDYL eflornithine hydrochloride INJECTABLE;INJECTION 019879-002 Nov 28, 1990 ➤ Sign Up ➤ Sign Up
Skinmedica VANIQA eflornithine hydrochloride CREAM;TOPICAL 021145-001 Jul 27, 2000 ➤ Sign Up ➤ Sign Up
Skinmedica VANIQA eflornithine hydrochloride CREAM;TOPICAL 021145-001 Jul 27, 2000 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Cantor Fitzgerald
Argus Health
McKinsey
Daiichi Sankyo
Merck
Fish and Richardson
QuintilesIMS
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot